Apellis Pharmaceuticals Inc. (APLS) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Sat March 27th, 2021

- 15:31
  EarningsAnalysisApellis Pharmaceuticals, Inc. (APLS) Down 7.9% Since Last Earnings Report: Can It Rebound?Zacks

Fri March 5th, 2021

- 10:58
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Apellis Pharmaceuticals To Stop Testing APL-9 In Severe COVID-19 PatientsBenzinga

Tue March 2nd, 2021

- 14:40
  AnalysisGemini Therapeutics: Precision Medicine Company Focused On Dry AMDSeeking Alpha

Mon March 1st, 2021

- 04:13
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha

Fri February 26th, 2021

- 18:41
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisApellis Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call PresentationSeeking Alpha
- 15:14
  EarningsAnalysisApellis' (APLS) Q4 Earnings Rise Y/Y, Pegcetacoplan in FocusZacks + 1 more

Thu February 25th, 2021

- 22:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisApellis Pharmaceuticals, Inc. (APLS) Tops Q4 Earnings and Revenue EstimatesZacks

Thu February 18th, 2021

- 10:07
  AnalysisApellis Is A Long-Term Name To Own Based On PNH Data AloneSeeking Alpha

Mon December 28th, 2020

- 15:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisApellis' (APLS) Pipeline Candidate Pegcetacoplan PromisingZacks

Fri November 20th, 2020

- 17:05
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisApellis (APLS) Begins Dosing With Pegcetacoplan in ALS StudyZacks

Tue November 17th, 2020

- 15:07
  AnalysisApellis' (APLS) Blood Disorder Drug Gets FDA's Priority TagZacks

Thu November 12th, 2020

- 09:24
  AnalysisBioCryst Pharmaceuticals: BCX9930's Competitive Profile In PNH PatientsSeeking Alpha

Tue November 3rd, 2020

- 15:29
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisApellis Pharmaceuticals' (APLS) Q3 Loss Wider Than ExpectedZacks

Sat October 31st, 2020

- 00:05
  AnalysisApellis Pharmaceuticals (APLS) COVID-19 Study Updates - SlideshowSeeking Alpha
- 00:04
  AnalysisApellis Pharmaceuticals (APLS) & Sobi Collaboration for Systemic Pegcetacoplan - SlideshowSeeking Alpha

Tue October 27th, 2020

- 12:31
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  90
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesSFJ Pharmaceuticals® partner, Apellis, enters Strategic Collaboration with Sobi to Develop and Commercialize Pegcetacoplan in Hematologic Indications outside the U.S.PR Newswire

Mon October 5th, 2020

- 16:33
  AnalysisBioCryst's BCX9930: Alexion's Biggest Headache NowSeeking Alpha

Wed September 16th, 2020

- 13:43
  AnalysisApellis Submits Pegcetacoplan Applications to FDA and EMAZacks

Tue September 1st, 2020

- 11:34
  AnalysisApellis Pharmaceuticals started at buy with $40 stock price target at Stifel NicolausMarketWatch

Sun August 30th, 2020

- 15:30
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisWhy Is Apellis Pharmaceuticals, Inc. (APLS) Down 3.8% Since Last Earnings Report?Zacks

Thu July 9th, 2020

- 06:44
  AnalysisApellis Trial Progress And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Sun July 5th, 2020

- 07:31
  AnalysisPolyPid Phase 3 And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Wed June 24th, 2020

- 18:50
  AnalysisApellis Pharmaceuticals (APLS) Investor Presentation - SlideshowSeeking Alpha

Fri June 12th, 2020

- 16:44
  AnalysisApellis Pharmaceuticals (APLS) PEGASUS Phase 3 Detailed Results Conference Call - SlideshowSeeking Alpha

Wed June 10th, 2020

- 18:44
  AnalysisAlexion Pharmaceuticals: Patent Resolution Is Too Little Too LateSeeking Alpha

Fri May 22nd, 2020

- 15:19
  Applied Genetic Reports Positive Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

SPY$395.63-4.9%

QQQ$315.85-7.5%

DOW$64.14-0.67%

AAPL$121.1-10%

MS$80.19-0.78%

PINS$69.6-18%

SPLK$134.8-9.2%

SPY$395.63-4.9%

QQQ$315.85-7.5%

DOW$64.14-0.67%

AAPL$121.1-10%

MS$80.19-0.78%

PINS$69.6-18%

SPLK$134.8-9.2%

About Developer Contact